Search Results
Dr. Snyder on the Utility of Transplant in MPNs
Dr. Snyder on Transplant Updates in Myelofibrosis
Dr. Snyder on How Ruxolitinib and Fedratinib May Pave the Way to Transplant in Myelofibrosis
Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis
Meet Hematologist David S. Snyder, M.D. | City of Hope
Dr. Snyder on the Quest to Revolutionize Management of Myelofibrosis
Stem Cell Transplant for Myelofibrosis in the JAK2 Inhibitor Era
Dr. Rossetti on the Utility of JAK Inhibitors in MPNs
Transplantation in patients with myelofibrosis
Dr David Snyder Outlines Use of Ruxolitinib After Approval of Fedratinib
Understanding Treatments for MPNs: Are There New or Emerging Treatments That Could Be Right For Me
Q&A Session for Myelofibrosis
